ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)
Clinical trial NCT00090363 · COMPLETED
Trial details
- NCT number
- NCT00090363
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2008-12-01
- Enrollment
- 447
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.